Barrington Research Weighs in on Stericycle Inc.’s FY2017 Earnings (SRCL)
Stericycle Inc. (NASDAQ:SRCL) – Equities research analysts at Barrington Research lowered their FY2017 earnings per share estimates for Stericycle in a research note issued to investors on Wednesday. Barrington Research analyst K. Steinke now anticipates that the brokerage will earn $4.79 per share for the year, down from their prior forecast of $5.10. Barrington Research currently has a “Outperform” rating and a $88.00 target price on the stock.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.18. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The company had revenue of $891.60 million for the quarter, compared to the consensus estimate of $910.29 million. During the same period in the prior year, the firm posted $1.14 EPS. Stericycle’s revenue for the quarter was up 24.6% on a year-over-year basis.
SRCL has been the subject of several other reports. Macquarie began coverage on Stericycle in a research report on Thursday, August 25th. They set a “neutral” rating and a $96.00 target price for the company. Jefferies Group restated a “buy” rating and issued a $112.50 price objective (down from $125.00) on shares of Stericycle in a report on Wednesday, September 7th. Zacks Investment Research upgraded Stericycle from a “sell” rating to a “hold” rating in a report on Monday, July 4th. Imperial Capital downgraded Stericycle from an “in-line” rating to an “underperform” rating and decreased their price objective for the company from $100.00 to $93.50 in a report on Friday, July 29th. Finally, Wellington Shields downgraded Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $103.54.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/07/barrington-research-weighs-in-on-stericycle-inc-s-fy2017-earnings-srcl.html
Shares of Stericycle (NASDAQ:SRCL) traded down 1.24% during mid-day trading on Friday, hitting $75.45. 592,033 shares of the stock were exchanged. The stock has a market cap of $6.42 billion, a PE ratio of 26.56 and a beta of 0.20. The stock’s 50 day moving average is $81.84 and its 200-day moving average is $99.57. Stericycle has a 12 month low of $75.20 and a 12 month high of $151.57.
In other news, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now owns 1,088 shares in the company, valued at $89,052.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rodney F. Dammeyer sold 10,188 shares of the business’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now owns 10,188 shares in the company, valued at approximately $871,074. The disclosure for this sale can be found here. Insiders own 3.30% of the company’s stock.
Several large investors have recently modified their holdings of SRCL. Vanguard Group Inc. raised its stake in shares of Stericycle by 1.8% in the second quarter. Vanguard Group Inc. now owns 7,471,494 shares of the company’s stock worth $777,932,000 after buying an additional 135,168 shares in the last quarter. State Street Corp raised its stake in shares of Stericycle by 0.5% in the first quarter. State Street Corp now owns 3,593,337 shares of the company’s stock worth $453,442,000 after buying an additional 19,317 shares in the last quarter. Baillie Gifford & Co. raised its stake in shares of Stericycle by 77.2% in the second quarter. Baillie Gifford & Co. now owns 2,940,515 shares of the company’s stock worth $306,166,000 after buying an additional 1,281,519 shares in the last quarter. Jana Partners LLC purchased a new stake in shares of Stericycle during the first quarter worth approximately $305,997,000. Finally, BlackRock Institutional Trust Company N.A. raised its stake in shares of Stericycle by 0.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,289,722 shares of the company’s stock worth $288,940,000 after buying an additional 19,063 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.